Monday, September 14, 2026

GC Cell Secures Japanese Certification for the Manufacture of Specific Cell Processing Products

GC Cell receives final certification from Japan for cell processing products, validating its manufacturing and quality systems for regenerative medicine.

Yoon Administration Decided To Distribute Anti-North Korea Leaflets One Year Before Proclaiming Martial Law… Confirmed By Military Investigation

The Yoon administration resumed anti-North Korea leaflet operations before declaring a state of emergency, prompting investigations into the actions.

VILE Hypocrisy: North Korea DEMANDS Japan Stop Defending Itself So Kim Can Attack Without Fear of Retaliation

North Korea criticizes Japan's defense enhancements, warning they could provoke severe retaliation from neighboring countries.

Tag: contract

North KoreaKoreaKimMilitaryAISouth Koreamarketrelationsdevelopment

Techwing Secures 9.1 Billion KRW Semiconductor Equipment Deal with Micron India: What This Means for the Future

Techwing signs a supply contract worth 9.184 billion KRW with Micron's India unit, expanding its delivery regions after Malaysia.

Yuhan Corp. Signs $874 Million API Supply Deal With Global Pharmaceutical Company

Yuhan Corp. has secured a long-term active pharmaceutical ingredient supply contract worth $874 million with a global pharmaceutical company, expanding its overseas export business.

How Kangstem Biotech’s Organoid Technology is Revolutionizing Skin Disease Treatment with Global Pharma Partnerships

Kangstem Biotech accelerates global expansion by signing a drug evaluation contract with a major pharmaceutical company for skin immune diseases.

Doosan Enerbility Secures Key Contract for TerraPower’s Advanced Sodium Reactor: What This Means for Nuclear Energy in 2026

Doosan Enerbility secures a contract for key equipment production for TerraPower's sodium reactor technology in the U.S.

Bukwang Pharm Signs Export Agreement With Thailand’s Pacific Healthcare for Dexid

Bukwang Pharmaceutical signs exclusive export contract for diabetes treatment 'Dexide' with Pacific Healthcare in Thailand.

K-Health Revolution: How Korean AI is Transforming Vietnam’s Healthcare Market

A South Korean digital healthcare firm secured an export deal in Vietnam, enhancing Korean AI medical services' global presence.

Samsung Biologics Expands Global Reach: New European Sales Office Set to Boost Biopharmaceuticals Market

Samsung Biologics expands its global sales network with a new office in Europe, aiming for growth in production and portfolio diversification.

Daewoong Pharmaceutical Expands Biosimilar Push With Dupixent Copy Deal and Global CDMO Partnership

Daewoong Pharmaceutical partners with Chime Biologics to develop a Dupixent biosimilar, enhancing its global biosimilar business expansion.

Matica BIOLABS Signs CMO with Jeongjin Bioscience for Mesenchymal Stem Cell Culture Media Production

Matica BIOLABS partners with Jeongjin Bioscience for stem cell media production and expands operations with Humic for drug development.

Pangen Expands Cell-Based Bioassay Services for Customized Drug Development

Pangen is expanding its cell-based activity analysis services after a new contract, enhancing drug evaluation capabilities for various medications.

Unlocking the Future of Cancer Treatment: UCI-101 CAR-NK Therapy by UCI Therapeutics

Matica BioLabs partners with UC Therapeutics to manufacture CAR-NK cell therapy, enhancing cancer treatment through dual-targeting technology.

LS Electric Secures $70 Million Deal for High-Voltage Transformers in AI Data Centers

LS Electric shares rose 5.46% after securing a $70.26 million transformer contract for a U.S. AI data center, scheduled for delivery by 2028.

Samsung Biologics America Achieves Record Profit: What This Means for Global Expansion in 2026

Samsung Biologics America reports record profits, showcasing its successful global expansion strategy despite previous revenue dips.

Estipam Secures Record 897 Billion KRW Contract for Oligonucleotide Raw Materials: What This Means for the Asian Market

ST Pharm secures a record 89.7 billion KRW contract for oligonucleotide ingredients, enhancing its global market position.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.